Fidelity® Select Medical Equip & Systems
(FSMEX)
US Markets Closed
AdChoices
39.23
+0.60
+1.55%
:

Previous Close

38.63

Net Assets

1.64B

Yield

0.00%

Front load

None

Expenses

0.79%

Category

Health

Morningstar Risk

Average

Morningstar Rating ★★
AdChoices
Performance
Returns %
Key statistics
  • Composition
  • Performance
  • Top Holdings
  • Top Rated Funds
  • Fund vs. Category
Quarterly Returns
  • Annual

  • FSMEX

  • Category

    • 2013

    • 41.30%

    • -

    • 2012

    • 15.62%

    • -

    • 2011

    • -3.42%

    • -

    • 2010

    • 12.71%

    • -

    • 2013

    • 2012

    • 2011

      • Q1

      • 13.84%

      • 14.68%

      • 8.63%

      • Q2

      • 3.40%

      • -1.19%

      • 4.04%

      • Q3

      • 7.81%

      • 5.32%

      • -14.68%

      • Q4

      • 11.34%

      • -3.12%

      • 0.16%

      Composition
      Sector Weightings
      Equity Investment Style
      The two dimensions of the Fund Style box measure the average size of companies that have been in the FUND, from the top to bottom, and the average valuation characteristics of the FUND's past stock holdings, from left to right.
      • Name

      • % Portfolio Weight

      • Shares Held

      • Change

        • Covidien PLC

        • 13.13

        • 2,550,000

        • -250,000

        • Boston Scientific Inc

        • 9.85

        • 13,100,000

        • 1,500,000

        • Medtronic Inc

        • 7.95

        • 2,100,000

        • 100,000

        • Abbott Laboratories

        • 6.14

        • 2,450,000

        • 0

        • Stryker Corporation

        • 4.94

        • 1,000,000

        • -150,000

        • Cooper Companies

        • 4.16

        • 430,000

        • -70,000

        • Edwards Lifesciences Corp

        • 4.00

        • 680,000

        • -50,000

        • Zimmer Holdings Inc

        • 3.53

        • 600,000

        • 120,000

        • ResMed Inc

        • 2.83

        • 900,000

        • 0

        • Intuitive Surgical Inc

        • 2.73

        • 98,000

        • -7,000

        • Name

        • Rating

        • YTD Return %

          • T. Rowe Price Health Sciences

          • ★★★★★
          • 22.66

          • VALIC Company I Health Sciences

          • ★★★★★
          • 22.36

          • Prudential Jennison Health Sciences A LW

          • ★★★★★
          • 22.77

          • Prudential Jennison Health Sciences Z

          • ★★★★★
          • 23.05

          • Vanguard Health Care Inv

          • ★★★★
          • 21.71

          • Fidelity® Select Biotechnology Portfolio

          • ★★★★
          • 25.03

          • Fidelity Advisor® Biotechnology T

          • ★★★★
          • 24.66

          • Fidelity Advisor® Health Care I

          • ★★★★
          • 24.58

          • BlackRock Health Sciences Opps Inv C

          • ★★★★
          • 20.62

          • Fidelity Advisor® Health Care C

          • ★★★★
          • 23.57

          • Name

          • FSMEX

          • Category

            • Expense Ratio

            • 0.79%

            • 1.45%

            • Net Assets

            • 1.64B

            • 711.24M

            • Dividend Yield

            • 0.84%

            • 0.61

            • Price/Book

            • 3.20

            • 4.82

            • Price/Sales

            • 3.24

            • 3.25

            • Price/Cash Flow

            • 17.19

            • 19.29

            Profile

            Name of Issuer

            Fidelity Investments

            Fund Style

            Open

            Fund Manager

            Edward Yoon

            Investment Style

            Medium Growth

            The investment seeks capital appreciation. The fund normally invests at least 80% of assets in securities of companies principally engaged in research, development, manufacture, distribution, supply, or sale of medical equipment and devices and related technologies. It invests primarily in common stocks. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.

            Purchase Information

            Initial Purchase 2,500
            Initial Purchase: IRA 500
            Initial Purchase: AIP 2,500
            Front load None
            Back Load None

            Inception

            4/28/1998